ArticleTargeted oncology2020

Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for Advanced EGFR-Positive Lung Adenocarcinoma Patients: Updated Data and Exploratory In Vitro Study.

Yuqing Lou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.